Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 631 publications

Advances in Neurological Therapies: A Review of Clinical Trials in Alzheimer's, Parkinson's, and Multiple Sclerosis.

Advances in Neurological Therapies: A Review of Clinical Trials in Alzheimer's, Parkinson's, and Multiple Sclerosis.

Journal: The American journal of medicine
Published: October 05, 2025

GLP-1 receptor agonists in Alzheimer's and Parkinson's disease: endocrine pathways, clinical evidence, and future directions.

GLP-1 receptor agonists in Alzheimer's and Parkinson's disease: endocrine pathways, clinical evidence, and future directions.

Journal: Frontiers in endocrinology
Published: September 18, 2025

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

Journal: JAMA surgery
Published: September 17, 2025

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

Journal: Diabetes, obesity & metabolism
Published: September 10, 2025

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review.

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review.

Journal: Journal of personalized medicine
Published: August 29, 2025

Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.

Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.

Journal: Diabetes, obesity & metabolism
Published: August 28, 2025

Seizure recurrence after GLP-1 receptor agonist initiation in adults with epilepsy.

Seizure recurrence after GLP-1 receptor agonist initiation in adults with epilepsy.

Journal: Epilepsia
Published: August 22, 2025

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.

Journal: Journal of the American College of Cardiology
Published: July 23, 2025

Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation.

Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation.

Journal: Medicine
Published: July 22, 2025

iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China.

iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China.

Journal: Diabetes, obesity & metabolism
Published: July 17, 2025

Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase.

Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase.

Journal: Journal of endocrinological investigation
Published: July 08, 2025

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study.

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study.

Journal: Diabetes, obesity & metabolism
Published: July 02, 2025
Showing 1-12 of 631

Last Updated: 01/07/2026